The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(4-(2-(5-cyclobutyl-1H-pyrazol-3-ylamino)-2-oxoethyl)phenoxy)-N-(4-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-ylamino)butyl)butanamide ID: ALA4864688
PubChem CID: 162749916
Max Phase: Preclinical
Molecular Formula: C36H41N7O7
Molecular Weight: 683.77
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(CCCOc1ccc(CC(=O)Nc2cc(C3CCC3)[nH]n2)cc1)NCCCCNc1cccc2c1C(=O)N(C1CCC(=O)NC1=O)C2=O
Standard InChI: InChI=1S/C36H41N7O7/c44-30(10-5-19-50-24-13-11-22(12-14-24)20-32(46)39-29-21-27(41-42-29)23-6-3-7-23)38-18-2-1-17-37-26-9-4-8-25-33(26)36(49)43(35(25)48)28-15-16-31(45)40-34(28)47/h4,8-9,11-14,21,23,28,37H,1-3,5-7,10,15-20H2,(H,38,44)(H,40,45,47)(H2,39,41,42,46)
Standard InChI Key: BEYPVZLSMWIZRD-UHFFFAOYSA-N
Molfile:
RDKit 2D
50 55 0 0 0 0 0 0 0 0999 V2000
18.8674 -14.1316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.8647 -14.9618 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1528 -13.7215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3065 -17.6841 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.4747 -15.5136 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3213 -16.1736 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.2831 -15.3463 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.1303 -17.6891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.7701 -19.1305 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
20.7789 -17.6981 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.1394 -16.2652 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.5493 -16.9815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3629 -18.4126 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
20.3709 -16.9776 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7675 -16.7858 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.1510 -15.3702 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4372 -14.9561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.4426 -14.1310 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5367 -18.4032 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.7239 -15.3636 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.4396 -14.1290 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2960 -14.9552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.4953 -14.9563 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.6884 -15.1258 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
3.2727 -14.4121 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8632 -14.9552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2889 -14.2152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1563 -15.3653 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.1549 -13.7143 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4385 -16.1911 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.4423 -14.9586 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4519 -14.3264 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0112 -14.1309 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2965 -13.7171 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
11.0101 -15.3659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.2952 -15.3659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1527 -14.9552 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8117 -14.8549 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8681 -14.1289 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.8669 -15.3659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.9329 -13.6924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.7244 -14.9552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5787 -14.1328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8228 -13.7991 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.0135 -14.9552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.5810 -14.9552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.7249 -13.7152 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.4385 -15.3659 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5776 -15.3659 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.0124 -14.9563 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10 14 1 0
1 3 2 0
17 16 1 0
11 5 1 0
13 9 2 0
13 10 1 0
8 4 2 0
19 13 1 0
3 18 1 0
11 12 1 0
18 17 2 0
12 14 1 0
12 8 1 0
16 6 1 0
6 11 1 0
5 2 1 0
8 19 1 0
2 16 2 0
6 15 2 0
2 1 1 0
5 7 2 0
17 20 1 0
33 34 1 0
46 36 1 0
34 43 1 0
28 26 1 0
49 26 1 0
44 25 2 0
39 29 1 0
36 45 1 0
25 32 1 0
29 21 2 0
25 24 1 0
33 50 2 0
24 23 1 0
37 40 1 0
38 32 1 0
23 43 2 0
40 46 1 0
45 20 1 0
21 47 1 0
41 27 1 0
35 22 1 0
32 41 1 0
42 35 1 0
26 39 2 0
42 48 1 0
43 44 1 0
27 38 1 0
21 31 1 0
31 28 2 0
47 33 1 0
48 37 1 0
22 49 1 0
48 30 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 683.77Molecular Weight (Monoisotopic): 683.3067AlogP: 3.43#Rotatable Bonds: 16Polar Surface Area: 191.69Molecular Species: NEUTRALHBA: 9HBD: 5#RO5 Violations: 1HBA (Lipinski): 14HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.13CX Basic pKa: 2.16CX LogP: 2.82CX LogD: 2.82Aromatic Rings: 3Heavy Atoms: 50QED Weighted: 0.11Np Likeness Score: -0.95
References 1. King HM, Rana S, Kubica SP, Mallareddy JR, Kizhake S, Ezell EL, Zahid M, Naldrett MJ, Alvarez S, Law HC, Woods NT, Natarajan A.. (2021) Aminopyrazole based CDK9 PROTAC sensitizes pancreatic cancer cells to venetoclax., 43 [PMID:33895280 ] [10.1016/j.bmcl.2021.128061 ]